The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 31, 2017

Filed:

Jul. 10, 2014
Applicant:

The Penn State Research Foundation, University Park, PA (US);

Inventors:

Gavin P. Robertson, Hummelstown, PA (US);

Raghavendra Gowda Chandagalu D., Hershey, PA (US);

Subbarao V. Madhunapantula, East Godavari District, IN;

Gajanan S. Inamdar, Hindalga, IN;

Omer F. Kuzu, Harrisburg, PA (US);

Assignee:

The Penn State Research Foundation, University Park, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/137 (2006.01); C07C 61/29 (2006.01); A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61K 31/135 (2006.01); A61K 31/136 (2006.01); A61K 31/155 (2006.01); A61K 31/17 (2006.01); A61K 31/19 (2006.01); A61K 31/215 (2006.01); A61K 31/26 (2006.01); A61K 31/195 (2006.01); A61K 45/06 (2006.01); C07C 211/31 (2006.01); C07C 229/38 (2006.01); C07C 265/08 (2006.01); C07C 275/24 (2006.01); C07C 279/04 (2006.01); C07C 331/24 (2006.01); C07C 335/02 (2006.01);
U.S. Cl.
CPC ...
C07C 61/29 (2013.01); A61K 9/0019 (2013.01); A61K 9/1271 (2013.01); A61K 31/135 (2013.01); A61K 31/136 (2013.01); A61K 31/137 (2013.01); A61K 31/155 (2013.01); A61K 31/17 (2013.01); A61K 31/19 (2013.01); A61K 31/195 (2013.01); A61K 31/215 (2013.01); A61K 31/26 (2013.01); A61K 45/06 (2013.01); C07C 211/31 (2013.01); C07C 229/38 (2013.01); C07C 265/08 (2013.01); C07C 275/24 (2013.01); C07C 279/04 (2013.01); C07C 331/24 (2013.01); C07C 335/02 (2013.01);
Abstract

Anti-cancer compositions and methods are described herein. In particular, compositions including one or more of leelamine, a leelamine derivative, abietylamine, an abietylamine derivative, and an abietic acid derivative are described. Methods for treatment of pathological conditions particularly cancer, in a subject using one or more of leelamine, a leelamine derivative, abietylamine, an abietylamine derivative, and an abietic acid derivative are described herein.


Find Patent Forward Citations

Loading…